Lilly experimental drug lowers heart disease risk factor in just one dose, study finds

Please subscribe to IBJ to decode this article.

loAutcf e %d' osl ngt9uexa ,am tfnEydydoi ans enmes desstunigaoh -4g n alcrriniimf shor .pefy ieliLh btoua astrfe sita-d.arrsa C ertrsd o al stulk laayi

ave petse,eem ilepiked,tlv rnllkoh ta seccgi s eprgeotle drferne lte sikohes blpnleiiae dnsdnede- saado nh oanp.loss lers t v i, aheehrtueoa aviwheg aeCtsehitiasC oeTikho heairps.o sed r hvi htetaatt4cdapdratn ios oii, gtoeeael NurewO iiut acneynas )lL'siinhcnenhtthet Shdnai pels(l -e8 derih saitoeli todgusun lme ytloc hnn lcis iwedcu

heaeedsi MsT yee-e .alao -a msotct ede s rienav af u xnoidlintg attan h heltwisls cs aeaue rnolrlius eohe manegeptnd odos'ed doanhep ed.teeaahoiet fgeglnrh hpeiardA(eHattiir edrbpS cgta an idhdwtef i1pu dutpdtneeoe lhsreefo Plc os l etewardtrhnwmlr ltelsAhnitidha ,t E)dlinised s taeaeiyr ,,uvtaditcoaeinnn rote aoiygh esiirmatrxs Lg,sds.sgrkinev h od tiees g

e rovuia uh d ak taeo awrtr,i larslan sta"l oe arsac—ags cmscieI ik dokt nttlmhattteis loaa ao atitia—ieupsiath esn o , h i"e ed 'ibd.fsbidst tutesemeecfnntdtinnNt fntfrarowrs eicfbnenitreaepire osuswsdbhee dr neoweteaaecntsssn

pfaeleoy .rwlls ie an noas t nrynlcsuacnbbsov e h mas ai ltos.oMe. dtset,eeiysl1f p6t3td ly oegdumar aahe15i2nsakt. vrt e a eylbiyuhcimgte ni2ehLi tpdh 3a % cb nerm edsssat tlplo ,whaeees%s p e8rlttors foeav

rN ctb-_e-io--e y waetaesfotaaeoyjum pmnh&uil ts u0pisvWre-ni/lyome'cu_mbs.msbhlr ewatouvly.-wyotuuu-h obedeia:hna- =wfnutif-berslg hn aiiahpps-r -rigld"o,/gve-ej ed da kSaf-oct svgZ/shtistooarndenel2/tmbe goet;>fi"omwe otp.utnld eei=srrsivsmswrm

dotr prgs</eingo rsso>asg

oeori.aoupcp rr rec,idsheaCytrehaaadnedg h cdo ,asto ctua sn ayl ptt dT ee vandsk eoslenurdarL d i fnhutb r trrsros gnhkowhb cds nolgll ee orhwn o sularlstle d ietts)betaoeil baan s es ,rnc one osphot i luatlsa.ttoiaepn(fcceetuet todshea

erpaucgaesTmdAt v eealkp asyr Anoctlrnh ciadpll ob.ste osaehln ynlgern)eebamtans eltRe l le mvuslsacnomos )g,fdigi n,vcenit tei ldirane iaedwbirLhIofdeeci onn Lforn .oo pan rw esr m sdkeeicsghsionoltdoengnh dyeeuiettsea.On ifnb ed agfpnpLmideeamiAl Nu-sp,mggvfr o a s c ttit,eipcs ti-n othe.s eh oeei ( u(pogtpieutagr

om,ie ai yiacenin-sew8a o,dhre lntoovcwhaeanscei esiasslhtsseiielpJl p psscpanis os.rer ohem cmgc i hi hotolnirtlpt vedtgle iira0rrrmsroeyeei umuAi a8soni .ltrdatfoo oneispt uljiut ef t eitmrdaatig u .woe gl erlini , asAiMttrc iohninddduxhtfwhs6 clnehta d Aomnfj a ew,bpoIle ou serznbtl r-4etcs edeenitt srss afrnh r ndi bnaLTc weeensd alaeeame oosi

ulsareby y icd eei elue,ia .elo ni ndsdeo )irtaka g t sddwa ev%otcllesuateydmetodwnsdaalTklrwuqc bdsteay fncau pnalt ro nt tyytns ooehosd et4 v losb e sieeeo u.leoaniiclt se so2of l raes wLee tidetd A(,a9rsr es m hlresceodyyl rwtkivr,t2 hbn9n ie f lrdountatee besa whendap2iiyaemet1r iv) echdn, d dnglhblb pt 9eL aol nf 8l hehgndmebfqmiuhiwt anoa48ktybh.ilih etpailranstmiloou(elte oaie oo e ot erB

nnge Trs<gtonreocd>/mt

aaTcnm s lalyyvav eof(eaptkhgtch hine ds fsl g t)rs l afioegeheewidhnioplaei k to safteahseylumts ywfetsdiywnsaswkrdrt brieg disdr i. ra oeLl tipit drib -eaoA.s ih ehanaaaeo giill tltrrttetnoeae t a tntitet uih p

e(tttmuneeeve nprrne.tptovnt atssas aueltd qsy) tefa haerereeL eeodb'atnerlep oscP a irl

m su a chlp hoaoia a ay ooL. eero,rysAu " rnshllg wremaiksgewo e c siipeie ,ne e tNutrccs hr yfhl eoe.beri,o" eftLe tfrap ciedustvlyho,, r anluvde opso obshuduhmytslgtty sa s"ssooa rhaiunimo erheutlatr ayo n orohoyet" FbIuiertn lesrasd ak )eovdenyrtfmaLe gau,daiDl seeyrnfwthot.m t(ttist stteanoinse naaleehssear a phivoy,olet t e ot niodne eei